
SLA: Preliminary Findings of BrainStorm’s Phase IIa Study Reported as “Extremely Optimistic”
BrainStorm Cell Therapeutics, a leading developer of adult stem cell technologies for…

BrainStorm Cell Therapeutics, a leading developer of adult stem cell technologies for…

Over 35 percent of American adults and 17 percent of American children…

New findings in mice suggest that merely changing meal times could have…

As part of the Hadassah Medical Center’s ART-Joy-Love project in Addis Ababa,…
Equivamed and smartphone app Convert Drugs Premium enables public health professionals to find the precise…